COMMUNIQUÉS West-GlobeNewswire

Tauriga Sciences Inc. to Issue Important and Material Shareholder Update Early Next Week

02/03/2018 - 21:00

NEW YORK, NY, March 02, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]

ICU Medical, Inc. to Present at Raymond James’ 39th Annual Institutional Investors Conference

02/03/2018 - 18:51

SAN CLEMENTE, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI ), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]

RavenQuest Expands National Presence; Completes Bloomera Acquisition

02/03/2018 - 18:00

VANCOUVER, British Columbia, March 02, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) ( the "RavenQuest") is pleased to announce that it has completed the acquisition of 8649081 Canada Inc. ("Bloomera"), a [...]

Otonomy Announces FDA Approval of OTIPRIO(R) for Acute Otitis Externa

02/03/2018 - 17:55

SAN DIEGO, March 02, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC ), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that the U.S. Food and Drug [...]

Tauriga Sciences Inc. Acquires Equity Stake in Colorado based NASDAQ Listed Biotechnology Firm Focused in the Medical Field of Urology

02/03/2018 - 17:35

NEW YORK, NY, March 02, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

02/03/2018 - 17:31

FIT Biotech Oy Company release March 2, 2018 at 6:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

02/03/2018 - 16:49

Copenhagen, 2018-03-02 16:49 CET (GLOBE NEWSWIRE) -- ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse [...]

ViaDerma, Inc. Refutes the Recent Announcement by Kasten, Inc.

02/03/2018 - 15:15

LOS ANGELES, March 02, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), announced today that it is refuting the announcement by Kasten, Inc. claiming he US District Federal Court ruled favorably for Kasten. [...]

HIMSS Analytics Honors Pagosa Springs Medical Center with Stage 7 Recognition

02/03/2018 - 15:01

PAGOSA SPRINGS, Colo., March 02, 2018 (GLOBE NEWSWIRE) -- Pagosa Springs Medical Center (PSMC) is proud to announce it has achieved Stage 7 of the Electronic Medical Record Adoption Model SM (EMRAM) from Healthcare [...]

Patient Home Monitoring Releases First Quarter Financial Results

02/03/2018 - 15:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, March 02, 2018 (GLOBE NEWSWIRE) -- Patient Home [...]

RavenQuest Completes Financings for $24.5 Million

02/03/2018 - 15:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, March [...]

Abattis Announces Successful Completion of Acquisition of Gabriola Green Farms

02/03/2018 - 14:42

VANCOUVER, British Columbia, March 02, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its news release dated February [...]

INSYS Therapeutics Initiates Phase 3 Clinical Trial of Cannabidiol (CBD) Oral Solution for Treatment of Infantile Spasms

02/03/2018 - 14:30

PHOENIX, March 02, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]

First Choice Healthcare Solutions Announces Closing of Strategic Partnership with Steward Health Care

02/03/2018 - 14:30

MELBOURNE, Fla., March 02, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB:FCHS) ("First Choice" or the "Company"), a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]

Histogenics to Showcase NeoCart® at American Academy of Orthopedic Surgeons and Orthopedic Research Society 2018 Annual Meetings

02/03/2018 - 14:30

WALTHAM, Mass., March 02, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX ), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]

Zosano Pharma Announces Issuance of New U.S. Patent Covering M207 as an Acute Treatment for Migraine

02/03/2018 - 14:30

FREMONT, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corp. (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical stage biopharmaceutical company focused on providing rapid systemic administration of [...]

Progressive Care Executes Letter of Intent to Purchase a Pharmacy in Palm Beach County

02/03/2018 - 14:22

MIAMI, March 02, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that it has executed a letter of intent to purchase a pharmacy in Palm Beach County. [...]

Sonoma Pharmaceuticals Announces Pricing of $5 Million Public Offering of Common Stock

02/03/2018 - 14:00

PETALUMA, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, Warrants – SNOAW) today announced the pricing of a “best efforts” public offering of up to 1,428,571 shares of common [...]

Paratek Pharmaceuticals to Present at the 38th Annual Cowen & Co. Health Care Conference

02/03/2018 - 14:00

BOSTON, March 02, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ) today announced that President, Chief Operating Officer and Chief Medical Officer, Evan Loh, MD, will present at the upcoming 38th [...]